Mode
Text Size
Log in / Sign up
Phase 4 N=108 Randomized Single-blind Treatment

Antibiotic Resistance In Eye Surgeries

Antibiotic Resistance · Ocular Surface Microbiome · Gut Resistome

Enrolled (actual)
108
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcome: Primary: Antimicrobial Resistance (AMR) of Conjunctiva at 1 Week — 0; 0; 0 reads per million reads — p=1

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Moxifloxacin (Topical) (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of California, San Francisco
Primary completion
Aug 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Antimicrobial Resistance (AMR) of Conjunctiva at 1 Week
0; 0; 0 1
SECONDARY
Antimicrobial Resistance (AMR) of Nasopharynx at 1 Week
0; 0; 0
SECONDARY
Shannon's Index
14; 14; 17
SECONDARY
Simpson's Index
6; 8; 5
SECONDARY
Simpson's Index
6; 8; 5

Summary

In this study, the investigators seek to determine the effect of antibiotic use post-surgery on antimicrobial resistance. The investigators will be studying adults (aged 18 or older) who will undergo eye surgery at University of California, San Francisco (UCSF). We seek to gain a better understanding of how antibiotic use during the perioperative period influences local and systemic antibiotic resistance at the individual level.

Eligibility Criteria

Inclusion Criteria

  • Over 18 years of age
  • Undergoing cataract surgeries that would benefit from intracameral antibiotics
  • Able to provide swabs
  • Able to provide consent
  • Surgery of the second eye occurs at least 8 weeks after surgery of the first eye

Exclusion Criteria

  • Same-day bilateral cataract surgeries
  • On immunosuppression medication such as Prednisone, Methotrexate, Cellcept, or anti-TNF inhibitors within past 3 months
  • On systemic antibiotic within past 3 months
  • On topical antibiotics within past 8 weeks
  • Allergies to fluoroquinolone
  • Patients needing glaucoma drainage device or trabeculectomy
  • Inability to consent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04750655). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search